Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging Advanced AI Frameworks for Dual PPAR α/γ Agonist Discovery in Alzheimer's Disease.

ACS chemical neuroscience·2026
Same author

Role of Luteolin in Prevention of Oral, Esophageal, Gastric, Pancreatic, and Colon Cancers: Recent Trends and Future Perspectives.

Journal of biochemical and molecular toxicology·2026
Same author

Emerging Near-Infrared Targeted Imaging Pharmaceutics for Ovarian Cancer.

Pharmaceutics·2026
Same author

Enhanced recovery of high-quality DNA from limited FFPE tissue for advancing cancer genomics.

Scientific reports·2026
Same author

Glycoprotein mucin 13 expression as a theranostic target in colorectal cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Biodegradable PCL-PLGA Electrospun Nanofibers for Localized Cancer Therapy.

ACS applied bio materials·2026

Related Experiment Video

Updated: Apr 25, 2026

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

1.4K

MUC13-Associated Molecular Interactome in Pancreatic Cancer.

Anupam Dhasmana1,2, Swati Dhasmana1,2, Rajasekhar Baru1,2

  • 1Division of Immunology and Microbiology, Department of Medicine and Oncology, ISU, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.

Computational and Structural Biotechnology Journal
|April 24, 2026
PubMed
Summary

Mucin-13 (MUC13) is crucial in pancreatic cancer. This study maps its interactome, revealing 54 proteins involved in cancer progression and immune evasion, offering new therapeutic targets.

More Related Videos

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.5K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.2K

Related Experiment Videos

Last Updated: Apr 25, 2026

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

1.4K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.5K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.2K

Area of Science:

  • Oncology
  • Molecular Biology
  • Proteomics

Background:

  • Mucin-13 (MUC13) is implicated in tumorigenesis, cancer progression, metastasis, and immune evasion, particularly in pancreatic cancer.
  • Understanding MUC13's molecular interactions is vital for elucidating its role in cancer.

Purpose of the Study:

  • To identify the MUC13 molecular interactome.
  • To determine the functional protein-protein interaction network and associated oncogenic mechanisms of MUC13.
  • To explore MUC13's role in pancreatic cancer progression.

Main Methods:

  • Integrated immunoprecipitation and liquid chromatography-mass spectrometry (LC-MS/MS) approach.
  • Systems network biology analysis to map protein-protein interactions.
  • Protein data accession no. JPST004189.

Main Results:

  • Identified 54 key MUC13 interactor proteins, including cyclin-dependent kinase 1, catenin delta 1, and tight junction protein 1.
  • The majority of interactors are associated with oncogenic and immune checkpoint pathways (e.g., PD-1/PD-L1, TCR signaling).
  • MUC13 interactors are involved in apoptosis, autophagy, senescence, and endoplasmic reticulum protein processing.

Conclusions:

  • This study provides the first comprehensive map of the MUC13-associated molecular interactome.
  • MUC13 network contributes to pancreatic cancer progression and metastasis.
  • Disrupting the MUC13 network offers potential therapeutic strategies against pancreatic cancer.